Cover Image

PDGFR-β mediated growth failure in pediatric CML cases on Imatinib

Saved in:

Bibliographic Details
Main Authors:	Prakamya Gupta (Author), Pinaki Dutta (Author)
Format:	Book
Published:	Elsevier, 2020-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients
by: Anastasia Putri, et al.
Published: (2019)

Imatinib inhibits pericyte-fibroblast transition and inflammation and promotes axon regeneration by blocking the PDGF-BB/PDGFRβ pathway in spinal cord injury
by: Fei Yao, et al.
Published: (2022)

Determination of the Cut-off Value for Imatinib Plasma Levels Linked to Occurrence of Bone Pain in CML Patients
by: Hamza MS, et al.
Published: (2022)

CircRNA Microarray Profiling Reveals hsa_circ_0058493 as a Novel Biomarker for Imatinib-Resistant CML
by: An-Ni Zhong, et al.
Published: (2021)

M2 Macrophages Promote PDGFRβ+ Pericytes Migration After Spinal Cord Injury in Mice via PDGFB/PDGFRβ Pathway
by: Ziyu Li, et al.
Published: (2021)

Distribution of common BCR-ABL fusion transcripts and their impact on treatment response in Imatinib treated CML patients: A study from India
by: Sudha Sazawal, et al.
Published: (2019)

Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
by: Simone Romagnoli, et al.
Published: (2021)

Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients
by: Henrike Jacobi, et al.
Published: (2023)

Profile of imatinib in pediatric leukemia
by: Burke MJ
Published: (2014)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance
by: Tim Fischer, et al.
Published: (2018)

Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy
by: Anca Maria Cimpean, et al.
Published: (2010)

Treatment and long-term follow-up of children with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): Experience from the Tata Memorial Hospital pediatric CML cohort over 2 decades
by: Nirmalya Roy Moulik, et al.
Published: (2022)

Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes
by: Kadivar A, et al.
Published: (2017)

The Activation of PDGFRβ on Mononuclear Stromal/Tumor Cells in Giant Cell Tumor of Bone After Denosumab Treatment. An Immunohistochemical Study of Five Cases
by: Imre Antal, et al.
Published: (2022)

Reversing Pdgfrβ signaling restores metabolically active beige adipocytes by alleviating ILC2 suppression in aged and obese mice
by: Abigail M. Benvie, et al.
Published: (2024)

The treatment of pediatric chronic myelogenous leukemia in the imatinib era
by: Jae Wook Lee, et al.
Published: (2011)

PDGFRβ-specific affibody-directed delivery of a photosensitizer, IR700, is efficient for vascular-targeted photodynamic therapy of colorectal cancer
by: Qiuxiao Shi, et al.
Published: (2017)

Effects of ginsenoside Rb1 on second-degree burn wound healing and FGF-2/PDGF-BB/PDGFR-β pathway modulation
by: Li Zhang, et al.
Published: (2021)

Sestrin-2, a repressor of PDGFRβ signalling, promotes cigarette-smoke-induced pulmonary emphysema in mice and is upregulated in individuals with COPD
by: Juliana Heidler, et al.
Published: (2013)

Global identification of circular RNAs in imatinib (IM) resistance of chronic myeloid leukemia (CML) by modulating signaling pathways of circ_0080145/miR-203/ABL1 and circ 0051886/miR-637/ABL1
by: Yao-hua Lu, et al.
Published: (2021)

Downregulation of ICCs and PDGFRα+ cells on colonic dysmotility in hirschsprung disease
by: Aiming Gu, et al.
Published: (2023)

Correction to: Fischer et al., Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance
Published: (2018)

Role of Immunohistochemistry in the Differential Diagnosis of Pediatric Renal Tumors: Expression of Cyclin D1, Beta-Catenin , PDGFR-Alpha, and PTEN
by: Nuray KEPIL, et al.
Published: (2022)

Theaflavin-3,3'-Digallate from Black Tea Inhibits Neointima Formation Through Suppression of the PDGFRβ Pathway in Vascular Smooth Muscle Cells
by: Yichen Wu, et al.
Published: (2022)

Y-box Protein-1 Regulates the Expression of Collagen I in Hepatic Progenitor Cells via PDGFR-β/ERK/p90RSK Signalling
by: Fei Li, et al.
Published: (2017)

Quantitative proteomics reveals the protective effects of Yinchenzhufu decoction against cholestatic liver fibrosis in mice by inhibiting the PDGFRβ/PI3K/AKT pathway
by: Qian Meng, et al.
Published: (2024)

Endothelial Cells Promote Migration of Mesenchymal Stem Cells via PDGF-BB/PDGFRβ-Src-Akt in the Context of Inflammatory Microenvironment upon Bone Defect
by: Sihao He, et al.
Published: (2022)

Exosomes from Bone Marrow Microenvironment-Derived Mesenchymal Stem Cells Affect CML Cells Growth and Promote Drug Resistance to Tyrosine Kinase Inhibitors
by: Xiaoyan Zhang, et al.
Published: (2020)

Physiologically based pharmacokinetic modeling of imatinib and N‐desmethyl imatinib for drug-drug interaction predictions
by: Helena Leonie Hanae Loer, et al.
Published: (2024)

Imatinib induced lichen planus
by: R Sudha, et al.
Published: (2011)

Advances in Small-Molecule C-KIT/PDGFRα Inhibitors for the Treatment of Gastrointestinal Stromal Tumors
by: Xuan Zheng, et al.

Imatinib- and Nilotinib-Induced Lichenoid Eruption in Chronic Myeloid Leukemia: A Rare Case Report
by: Meenakshi Sachdeva, et al.
Published: (2023)

Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia
by: Hyun Jin Oh, et al.
Published: (2013)

Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment
by: Erin Clapper, et al.
Published: (2020)

Listen to the patients! Identifying CML patients' needs analyzing patient-generated content with AI-driven methodologies
by: Stefanie Scholz, et al.
Published: (2023)

Evaluation of CML TKI Induced Cardiovascular Toxicity and Development of Potential Rescue Strategies in a Zebrafish Model
by: Shan Cheng, et al.
Published: (2021)

Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells
by: Anne Trinh, et al.
Published: (2022)

Pdgfrα functions in endothelial-derived cells to regulate neural crest cells and the development of the great arteries
by: Haig Aghajanian, et al.
Published: (2017)

Imatinib-induced melasma-like pigmentation
by: Sweta Subhadarshani, et al.
Published: (2019)

Drug-induced hyperpigmentation due to imatinib
by: Savitha Murali, et al.
Published: (2023)